8 months ago
Gujarat Kidney IPO Sees Strong Demand
Gujarat Kidney & Super Speciality, a healthcare company, recently had its IPO.
The IPO was very popular and got subscribed 5.21 times, especially by regular and small investors.
The company plans to use the money raised to buy hospitals, get new equipment, and pay off some debts.
The shares are expected to start trading on December 29, 2025.
Investors can check if they got shares on the BSE, NSE, or through the IPO registrar.
The company runs several hospitals and pharmacies in Gujarat and has been growing its profits and revenue.
Gujarat Kidney's IPO was subscribed 5.21 times, with strong demand from retail and NII investors.
The grey market premium (GMP) is ₹0, suggesting the stock may debut at the IPO price of ₹114.
The ₹250.80 crore IPO is entirely a fresh issuance of 2.20 crore shares.
Proceeds will be used for acquiring hospitals, capital expenditure, and general corporate purposes.
The company operates 7 multispeciality hospitals and 4 pharmacies, with a total of 490 beds.
- Who
- Gujarat Kidney & Super Speciality
- What
- IPO subscription and allotment
- Where
- BSE and NSE
- When
- December 22-24, 2025 (subscription), December 26, 2025 (allotment), December 29, 2025 (listing)
- Why
- To raise funds for acquisitions, capital expenditure, and general corporate purposes
Investor Sentiment
Market Performance
Grey Market Premium
Investor Sentiment
The grey market premium (GMP) for Gujarat Kidney's IPO is ₹0, indicating muted investor sentiment and suggesting the stock may debut at the IPO price of ₹114.
Market Performance
Despite the muted GMP, the IPO was subscribed 5.21 times, showing strong demand, particularly from retail and NII investors.
Key facts
- IPO Subscription
- 5.21 times
- Retail Subscription
- 19.04 times
- NII Subscription
- 5.73 times
- QIB Subscription
- 1.06 times
- IPO Size
- ₹250.80 crore
- Price Band
- ₹108-₹114 per share
- Allotment Date
- December 26, 2025
- Listing Date
- December 29, 2025
- Anchor Investors
- Over ₹100 crore raised
- Lead Manager
- Nirbhay Capital Services
- Registrar
- MUFG Intime India Pvt. Ltd
- Hospitals Operated
- 7 multispeciality hospitals and 4 pharmacies
- Beds Available
- 490 beds
- Net Profit FY25
- ₹9.49 crore
- Revenue FY25
- ₹40.24 crore
Timeline
Blue Water Logistics kicks off IPO at Rs 132–135 per share on May 27.
Then, strong investor interest drives Global Ocean Logistics' IPO to oversubscription.
In response, shares soar to Rs 79.20 upon listing.
Trading begins at Rs 79.20 after hotly contested IPO
Quotes
StoxBoxx
A financial research and advisory firm
“Gujarat Kidney & Super Speciality's outlook remains positive, braced by strong demand for chronic and specialty healthcare, expansion of bed capacity and specialties, increasing insurance coverage and government healthcare support in Gujarat. The issue is valued at a P/E multiple of 61.6 times FY25 earnings. We recommend a 'subscribe' rating for the IPO.”
businesstoday.in
Hem Securities
A financial services and investment advisory firm
“The issue is valued at a P/E multiple of more than 40 times on post issue annualized Q1FY25 PAT basis. It has a track record of operating and financial performance and growth along with professional management and experienced leadership. Hence, we recommend 'long term subscribe' rating to the issue.”
businesstoday.in
Sources
Gujarat Kidney & Super Speciality AMC IPO subscription: Check day 3 bidding & latest GMP
Gujarat Kidney IPO: Here's what GMP ahead of allotment suggests
Global Ocean Logistics IPO listing: Shares list at 1.5% premium over IPO price, extend gains
Last day to buy Gujarat Kidney IPO: Check GMP, subscription status, IPO review - Apply or not?
Gujarat Kidney IPO booked 5.2x on final day; retail investors show strong interest, GMP indicates muted listing
Gujarat Kidney IPO Day 3 LIVE: Last day to apply for IPO — Check latest GMP, review and other details
Gujarat Kidney and Super Speciality IPO subscribed 4.62 times so far on final day
Gujarat Kidney IPO Subscribed 5.2x On Last Day
Related news
NSE derivatives turnover falls below ₹200 lakh crore in August
Vodafone Idea Shares Rise as Brand Revamp Draws Investor Attention
Augmont Enterprises Rises Despite Gold-Buying Appeal and Market Risks
BSE Shares Fall as New Closing Auction Session Draws Scrutiny
BSE Seeks Common Order Book to Boost Closing Auctions
